These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19916323)

  • 1. [Adiponectin: pathophysiological aspects].
    Schwarz V
    Patol Fiziol Eksp Ter; 2009; (3):34-8. PubMed ID: 19916323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adiponectin, a new hormone: its role in the pathogenesis of diabetes mellitus].
    Pankov IuA
    Vestn Ross Akad Med Nauk; 2006; (9-10):99-104. PubMed ID: 17111933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin signaling and metabolic syndrome.
    Fu Y
    Prog Mol Biol Transl Sci; 2014; 121():293-319. PubMed ID: 24373241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
    Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K; Tobe K
    J Clin Invest; 2006 Jul; 116(7):1784-92. PubMed ID: 16823476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
    Owecki M; Sowiński J
    Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of adiponectin and adipolin as anti-inflammatory adipokines in the formation of macrophage foam cells and their association with cardiovascular diseases.
    Sargolzaei J; Chamani E; Kazemi T; Fallah S; Soori H
    Clin Biochem; 2018 Apr; 54():1-10. PubMed ID: 29452073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of adiponectin in the pathogenesis of the metabolic syndrome and approach to therapy].
    Rodina AV; Severin SE
    Patol Fiziol Eksp Ter; 2013; (1):15-26. PubMed ID: 23805709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adiponectin and cardiovascular diseases].
    Zhang P; Wang NP
    Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):149-52. PubMed ID: 17633232
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adiponectin and chronic viral hepatitis].
    Yin HZ; Cao ZC
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):955-7. PubMed ID: 20038346
    [No Abstract]   [Full Text] [Related]  

  • 11. Adiponectin-Resistance in Obesity.
    Engin A
    Adv Exp Med Biol; 2017; 960():415-441. PubMed ID: 28585210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin in diabetes mellitus.
    Xita N; Tsatsoulis A
    Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Vegan Protein-Based Diets on Metabolic Parameters, Expressions of Adiponectin and Its Receptors in Wistar Rats.
    Chen JH; Song J; Chen Y; Ding Q; Peng A; Mao L
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27763537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
    Reddy KJ; Singh M; Bangit JR; Batsell RR
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adiponectin receptor regulation in diabetic states].
    Inukai K; Awata T; Katayama S
    Nihon Rinsho; 2007 Nov; 65(11):2125-30. PubMed ID: 18018580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin receptors: a review of their structure, function and how they work.
    Yamauchi T; Iwabu M; Okada-Iwabu M; Kadowaki T
    Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):15-23. PubMed ID: 24417942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders.
    Francischetti EA; Dezonne RS; Pereira CM; de Moraes Martins CJ; Celoria BMJ; de Oliveira PAC; de Abreu VG
    Horm Metab Res; 2020 Oct; 52(10):695-707. PubMed ID: 32927496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin and adiponectin receptors.
    Kadowaki T; Yamauchi T
    Endocr Rev; 2005 May; 26(3):439-51. PubMed ID: 15897298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.